Trial Profile
Clinical Trials Insight: 700052208
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Dec 2009
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; Lamivudine
- Indications Hepatitis B
- Focus Pharmacodynamics; Therapeutic Use
- 30 Dec 2009 New trial record.